<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01415830</url>
  </required_header>
  <id_info>
    <org_study_id>BIRMEX-ECA-03-2011</org_study_id>
    <nct_id>NCT01415830</nct_id>
  </id_info>
  <brief_title>Compare Two Anti-Scorpion Venom Serum In Children</brief_title>
  <official_title>Randomized Controlled Trial To Evaluate Efficacy And Safety Of The Polyvalent Anti-scorpion Venom Serum Of Birmex Versus Other Commercial Venom Serum In Children Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The morbidity associated with scorpion sting intoxication presents an endemic pattern in the
      country, where there are highly venomous species of scorpions so the scorpion sting
      intoxication (IPPA) is considered a medical emergency.

      On the other hand, there is scarce scientific literature from different controlled studies
      evaluating anti-scorpion serum, considering clinical severity scales, lab results and their
      safety. The aim of this study is to compare the efficacy and safety of scorpion sting
      treatment, using two sera, one produced by Birmex versus Alacramyn ® (Bioclon).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We consider relevant conduct this study because the poisoning scorpion bite represents a
      public health problem.

      This is a randomized clinical trial, which included 120 subjects of both sexes aged 0 and 15
      years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients
      received antiscorpion serum of Birmex and 60 patients receive other commercial serum
      (Alacramyn).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resolution of signs and symptoms of scorpion envenomation</measure>
    <time_frame>after treatment (expected average of 12 hrs)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the adverse events in every treated child</measure>
    <time_frame>inmediately after treatment and until 5 days later</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Scorpion Sting</condition>
  <arm_group>
    <arm_group_label>Anti-scorpion venom serum Birmex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients 0 to 15 years with scorpion sting, will receive serum antiscorpion elaborated by Birmex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anti-scorpion venom serum Alacramyn</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients 0 to 15 years with scorpion sting, will receive other commercial serum antiscorpion (Alacramyn)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Anti-scorpion venom serum Birmex</intervention_name>
    <description>the dose may be required for the patient according to clinical manifestations and evolution</description>
    <arm_group_label>Anti-scorpion venom serum Alacramyn</arm_group_label>
    <other_name>anti-scorpion venom serum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Anti-scorpion venom serum Alacramyn</intervention_name>
    <description>The dose may be required fot the patient according to clinical manifestations and evolution</description>
    <arm_group_label>Anti-scorpion venom serum Birmex</arm_group_label>
    <other_name>antiscorpion venom serum</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Scorpion sting

          2. Either sex

          3. Age 1 to 15 years

          4. Signing an informed consent (signed by parent or guardian)

          5. Being residents of the state of Guanajuato

        Exclusion Criteria:

          1. Previous treatment with gamma globulin or immunoglobulin

          2. Blood transfusion at any stage of life

          3. Patients treated with drugs that interact with anti-scorpion serum

          4. History or history of sensitivity or intolerance to anti-scorpion serum or horse
             products

          5. Pregnancy

          6. Any immunodeficiency

          7. Patients who have participated in a research protocol in the previous month.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ma. Eugenia Jimenez-Corona, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laboratorios de Biologicos y Reactivos de México SA de CV</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital General Regional de León</name>
      <address>
        <city>León</city>
        <state>Guanajuato</state>
        <zip>37320</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2011</study_first_submitted>
  <study_first_submitted_qc>August 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2011</study_first_posted>
  <last_update_submitted>February 5, 2013</last_update_submitted>
  <last_update_submitted_qc>February 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anti-Scorpion venom serum</keyword>
  <keyword>venom</keyword>
  <keyword>efficacy</keyword>
  <keyword>safety</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scorpion Stings</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

